For a strong Swiss medtech industry


Swiss Medtech was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative capacity, and to strengthen the domestic market.

Whether it be syringes, implants, wheelchairs, or MRIs - medical technology supplies people, doctors, and hospitals with vital products and applications. The domestic medtech industry generates annual sales of 15.8 billion and exports of 11.3 billion Swiss francs. It contributes 2.3% of the GDP. Swiss Medtech supports the Swiss medtech industry's continuing contribution to health care and the economy, as well as its ability to remain competitive internationally.

The Association represents the interests of the industry and serves 1,400 companies and 58,500 employees. It is committed to rapid patient access to innovation and high-quality standards. Swiss Medtech also initiates specialised training programmes, challenges rising levels of regulation, and pushes for free trade and fair tariffs. Together with its specialist groups and partners, the Association is committed to favourable conditions and to an attractive setting for research and other professional activities within Switzerland.

More in "portrait"

Quick access to focal topics


26 August 2019

Swiss Medtech's response to the consultation procedure on new medical device regulations


26 August 2019 – Swiss Medtech presents its position regarding the consultation procedure on new medical device regulations (complete revision of the Ordinance on Medical Devices MepV and the Ordinance on Clinical Trials of Medical Devices KlinV-Mep). Read more

MepV and KlinV-Mep - Swiss Medtech presses for a fundamental overhaul

13 August 2019 – Piavita is a Swiss-based medtech company that brings veterinary medicine into the 21st century. The company offers an innovative system for monitoring and recording vital signs of horses the veterinarian needs to make a safe, evidence-based decision. Read more

Piavita - Startup of the month of August

5 July 2019 – The Swiss conformity assessment body QS Zurich AG, EU marking number CE 1254, will terminate all conformity assessment activities in compliance with EU Directive 93/42/EEC on 31 October 2019, and is withdrawing its application for designation according to the EU Medical Device Regulation (EU) 2017/745. Their manufacturers of certificates according to Directive 93/42/EEC have already been informed. More information

QS Zurich AG discontinues activities as Notified Body for medical devices

Swiss Medtech

Swiss Medical Technology Association

Freiburgstrasse 3
3010 Berne


Member of:

New logo MTE 2017.png